← Back to Search

Exercise for Parkinson's Disease

N/A
Recruiting
Research Sponsored by The Cleveland Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up an average of 3 total days
Awards & highlights

Study Summary

This trial will study 25 people with Parkinson's Disease using a medical device to measure effects of exercise on the condition.

Who is the study for?
This trial is for adults with Parkinson's Disease (PD) who have had a Medtronic Percept PC DBS system in place for at least six months and stable settings for three. Participants must be able to stop PD medications and DBS, pass an exercise safety screening or get doctor clearance, and safely use a recumbent cycle.Check my eligibility
What is being tested?
The study tests the effects of one session each of forced (FE) and voluntary exercise (VE) on cognitive function in PD patients without their usual medication or DBS stimulation. The exercises are done during a single 150-minute session.See study design
What are the potential side effects?
Potential side effects from participating may include typical risks associated with physical exercise such as muscle strain, fatigue, or cardiovascular stress especially since participants will not take their regular PD medication during sessions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~an average of 3 total days
This trial's timeline: 3 weeks for screening, Varies for treatment, and an average of 3 total days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Force-tracking with n-back
Information Processing
Local Field Potentials during Cognitive Testing
+2 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Experimental ArmExperimental Treatment1 Intervention
Two modes of high intensity exercise.

Find a Location

Who is running the clinical trial?

The Cleveland ClinicLead Sponsor
1,030 Previous Clinical Trials
1,365,533 Total Patients Enrolled
United States Department of DefenseFED
865 Previous Clinical Trials
327,674 Total Patients Enrolled

Media Library

Experimental Arm Clinical Trial Eligibility Overview. Trial Name: NCT05972759 — N/A
Parkinson's Disease Research Study Groups: Experimental Arm
Parkinson's Disease Clinical Trial 2023: Experimental Arm Highlights & Side Effects. Trial Name: NCT05972759 — N/A
Experimental Arm 2023 Treatment Timeline for Medical Study. Trial Name: NCT05972759 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there presently any openings for participants in this experiment?

"According to clinicaltrials.gov, this research is no longer in need of participants after being added on August 15th 2023 and last edited a month later. In spite of this, there are still 1,095 other trials that require volunteers at the present time."

Answered by AI
~17 spots leftby Dec 2025